Document Format Files
| Seq | Description | Document | Type | Size |
|---|---|---|---|---|
| 1 | ANNUAL REPORT | ea0285148-20f_ascentage.htm iXBRL | 20-F | 6558208 |
| 2 | DESCRIPTION OF SECURITIES | ea028514801ex2-4.htm | EX-2.4 | 276254 |
| 3 | POST-IPO SHARE OPTION PLAN AS AMENDED ON MAY 19, 2025 | ea028514801ex4-5.htm | EX-4.5 | 167804 |
| 4 | 2021 RSU SCHEME AS AMENDED ON MAY 19, 2025 | ea028514801ex4-8.htm | EX-4.8 | 147702 |
| 5 | AMENDED AND RESTATED AMENDED PATENT LICENSE AGREEMENT BETWEEN ASCENTAGE PHARMA G | ea028514801ex4-12.htm | EX-4.12 | 113309 |
| 6 | LICENSE AGREEMENT BETWEEN ASCENTAGE PHARMA GROUP CORP LIMITED AND THE REGENTS OF | ea028514801ex4-13.htm | EX-4.13 | 110363 |
| 7 | OFFER LETTER BETWEEN ASCENTAGE PHARMA GROUP INC. AND VEET MISRA | ea028514801ex4-15.htm | EX-4.15 | 23806 |
| 8 | LIST OF SUBSIDIARIES OF THE REGISTRANT | ea028514801ex8-1.htm | EX-8.1 | 5059 |
| 9 | ENGLISH TRANSLATION OF ASCENTAGE PHARMA GROUP INTERNATIONAL INSIDER TRADING POLI | ea028514801ex11-1.htm | EX-11.1 | 150794 |
| 10 | CERTIFICATION | ea028514801ex12-1.htm | EX-12.1 | 13568 |
| 11 | CERTIFICATION | ea028514801ex12-2.htm | EX-12.2 | 13790 |
| 12 | CERTIFICATION | ea028514801ex13-1.htm | EX-13.1 | 4596 |
| 13 | CERTIFICATION | ea028514801ex13-2.htm | EX-13.2 | 6263 |
| 14 | CONSENT OF ERNST & YOUNG HUA MING LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING | ea028514801ex15-1.htm | EX-15.1 | 3710 |
| 15 | CONSENT OF WALKERS (HONG KONG) | ea028514801ex15-2.htm | EX-15.2 | 7146 |
| 16 | CONSENT OF JUNHE LLP | ea028514801ex15-3.htm | EX-15.3 | 4407 |
| 17 | CONSENT OF FROST & SULLIVAN | ea028514801ex15-4.htm | EX-15.4 | 4763 |
| 18 | ASCENTAGE PHARMA GROUP INTERNATIONAL COMPENSATION RECOVERY POLICY | ea028514801ex97-1.htm | EX-97.1 | 45941 |
| 19 | GRAPHIC | ea028514801_img1.jpg | GRAPHIC | 95123 |
| 20 | GRAPHIC | ea028514801_img2.jpg | GRAPHIC | 82665 |
| 21 | GRAPHIC | ea028514801_img3.jpg | GRAPHIC | 83252 |
| 22 | GRAPHIC | ea028514801_img4.jpg | GRAPHIC | 82665 |
| 23 | GRAPHIC | ea028514801_img5.jpg | GRAPHIC | 85036 |
| 24 | GRAPHIC | ea028514801_img6.jpg | GRAPHIC | 160078 |
| 25 | GRAPHIC | ea028514801_img7.jpg | GRAPHIC | 63196 |
| 26 | GRAPHIC | ea028514801_img8.jpg | GRAPHIC | 238794 |
| 27 | GRAPHIC | ea028514801_img9.jpg | GRAPHIC | 449108 |
| 28 | GRAPHIC | ea028514801_img10.jpg | GRAPHIC | 235365 |
| 29 | GRAPHIC | ea028514801_img11.jpg | GRAPHIC | 139524 |
| 30 | GRAPHIC | ea028514801_img12.jpg | GRAPHIC | 180096 |
| 31 | GRAPHIC | ea028514801_img13.jpg | GRAPHIC | 69452 |
| 32 | GRAPHIC | ea028514801_img14.jpg | GRAPHIC | 72390 |
| 33 | GRAPHIC | ea028514801_img15.jpg | GRAPHIC | 72421 |
| 34 | GRAPHIC | ea028514801_img16.jpg | GRAPHIC | 50532 |
| 35 | GRAPHIC | ea028514801_img17.jpg | GRAPHIC | 55485 |
| 36 | GRAPHIC | ea028514801_img18.jpg | GRAPHIC | 49439 |
| 37 | GRAPHIC | ea028514801_img19.jpg | GRAPHIC | 76595 |
| 38 | GRAPHIC | ea028514801_img20.jpg | GRAPHIC | 298936 |
| 39 | GRAPHIC | ea028514801_img21.jpg | GRAPHIC | 304105 |
| 40 | GRAPHIC | ea028514801_img22.jpg | GRAPHIC | 202725 |
| 41 | GRAPHIC | ea028514801_img23.jpg | GRAPHIC | 203777 |
| 42 | GRAPHIC | ea028514801_img24.jpg | GRAPHIC | 173003 |
| 43 | GRAPHIC | ea028514801_img25.jpg | GRAPHIC | 15831 |
| 44 | GRAPHIC | ea028514801_img26.jpg | GRAPHIC | 15152 |
| 45 | GRAPHIC | ea028514801_img27.jpg | GRAPHIC | 15225 |
| 46 | GRAPHIC | ea028514801_img28.jpg | GRAPHIC | 18408 |
| 47 | GRAPHIC | ea028514801_img29.jpg | GRAPHIC | 22417 |
| 48 | GRAPHIC | ea028514801_img30.jpg | GRAPHIC | 22079 |
| 49 | GRAPHIC | ea028514801_img31.jpg | GRAPHIC | 9740 |
| 50 | GRAPHIC | ea028514801_img32.jpg | GRAPHIC | 10029 |
| 51 | GRAPHIC | ea028514801_img33.jpg | GRAPHIC | 13546 |
| 52 | GRAPHIC | ea028514801_img34.jpg | GRAPHIC | 27152 |
| 53 | GRAPHIC | ea028514801_img35.jpg | GRAPHIC | 22240 |
| 54 | GRAPHIC | ea028514801_ex4-15img1.jpg | GRAPHIC | 4647 |
| 55 | GRAPHIC | ea028514801_ex15-2img1.jpg | GRAPHIC | 1843 |
| 56 | GRAPHIC | ea028514801_ex15-4img1.jpg | GRAPHIC | 54962 |
| Complete submission text file | 0001213900-26-049412.txt | 35527903 |
Data Files
| Seq | Description | Document | Type | Size |
|---|---|---|---|---|
| 57 | XBRL SCHEMA FILE | aapg-20251231.xsd | EX-101.SCH | 207849 |
| 58 | XBRL CALCULATION FILE | aapg-20251231_cal.xml | EX-101.CAL | 111801 |
| 59 | XBRL DEFINITION FILE | aapg-20251231_def.xml | EX-101.DEF | 707710 |
| 60 | XBRL LABEL FILE | aapg-20251231_lab.xml | EX-101.LAB | 1227615 |
| 61 | XBRL PRESENTATION FILE | aapg-20251231_pre.xml | EX-101.PRE | 743985 |
| 249 | EXTRACTED XBRL INSTANCE DOCUMENT | ea0285148-20f_ascentage_htm.xml | XML | 5288930 |
EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-42484 | Film No.: 26918112
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)